Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 0.56 million during the last session, with the company’s beta value hitting -0.96. At the close of
In the last trading session, 0.36 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -0.91. With the company’s per share
In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 0.32 million shares changing hands with its beta currently measuring -0.88. Company’s recent per share price
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 1.02 million during the last session, with the company’s beta value hitting -0.84. At the close of
In the last trading session, 5.16 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -0.73. With the company’s per share
During the last session, Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares were 0.84 million, with the beta value of the company hitting -0.56. At the end
In today’s recent session, 0.51 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) have been traded, and its beta is -0.75. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
